Farasat Zaman

Farasat Zaman

Senior Research Specialist
Visiting address: BioMedicum A4, Solnavägen 9, 17165 Solna
Postal address: K6 Kvinnors och barns hälsa, K6 Barnendokrinologi Sävendahl, 171 77 Stockholm


  • *Osteoporosis and bone growth failure in chronic paediatric diseases*
    The overall aim of these studies is to address unanswered core bone health
    questions such as osteoporosis/bone growth failure in the paediatric patients
    with chronic diseases and exposed to high dose glucocorticoid therapy. Some
    20% of paediatric patients treated with GCs experience multiple peripheral
    fractures, bone pain and vertebral compression fractures. We are currently
    investigating following disorders in which GCs are frequently used:
    * /Inflammation/
    * /Acute Lymphoblastic Leukemia (ALL)/
    * /Duchenne Muscular Dystrophy (DMD)/
    Impaired bone health is often present at diagnosis in these disorders, but
    poorly understood Severe osteoporosis is a frequent finding 1-3 years post
    diagnosis. Understanding the pathophysiology of disordered bone
    health/osteoporosis following glucocorticoids treatement in chronic
    conditions such as ALL, inflammation and DMD will lead to development of
    better treatment strategies in affected children. We are also investigating
    novel molecules/peptides in combination with GCs to prevent osteoporosis and
    bone growth failure in infllamtion, ALL and DMD.


All other publications


  • Senior Research Specialist, Department of Women's and Children's Health, Karolinska Institutet, 2021-

Degrees and Education

  • Degree Of Doctor Of Philosophy, Department of Women's and Children's Health, Karolinska Institutet, 2010

News from KI

Events from KI